Voloridge Investment Management
MDGL icon

Voloridge Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Voloridge Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-59,189
Closed -$14.3M – 1480
2023
Q1 		$14.3M Buy
59,189
+54,232
+1,094% +$14.8M 0.07% 363
2022
Q4 		$1.44M Buy
+4,957
New +$485K 0.01% 1050
2020
Q3 		– Sell
-20,174
Closed -$2.29M – 1398
2020
Q2 		$2.29M Buy
+20,174
New +$1.98M 0.03% 578
2019
Q1 		– Sell
-16,664
Closed -$1.88M – 1016
2018
Q4 		$1.88M Buy
+16,664
New +$2.58M 0.09% 206

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Voloridge Investment Management's MDGL Position: Q2 2023 in Review

Voloridge Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2023, closing a stake of 59,189 shares — an estimated $14.3M sold.

Voloridge Investment Management first reported a position in MDGL in Q4 2018 and held it in 4 quarters. The position peaked at $14.3M in Q1 2023. 208 funds tracked by Wall St. Rank hold MDGL as of Q2 2023.

  • Voloridge Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 59,189 Madrigal Pharmaceuticals shares in Q2 2023, an estimated $14.3M.
  • Voloridge Investment Management first reported a position in Madrigal Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Voloridge Investment Management's Madrigal Pharmaceuticals position peaked at $14.3M in Q1 2023.
  • 208 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2023.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.